Study ID | Study Type | Participants | Exposure (Caffeine/coffee) | Comparison | Outcomes | |||
---|---|---|---|---|---|---|---|---|
Gender | Age | Sample size | Disease | Relative Risk(95%CI) | ||||
Buiatti 1984 | Case-Control Study | Men | 20-54y | 239 | ≥100 mg/d | 0 mg/d | Azoospermia/oligospermia | OR = 0.91 (0.46–1.82) |
Grodstein 1993 | Case-Control Study | Women | Unclear | 4883 | E1 100-167mg/d; E2 168-233mg/d; E3>233mg/d | <100 mg/d | Primary infertility | OR1 = 1.00(0.79–1.25); OR2 = 1.16(0.94–1.42); OR3 = 1.36(1.16–1.60) a,b |
Prazzini 1993 | Case-Control Study | Men | Median 31-33y | 216 | E1 200-300 mg/d; E2 ≥ 400 mg/d | 0-100 mg/d | Infertile men with dyspermia | OR1 = 1.7(0.8–3.7); OR2 = 5.4 (2.4–12.6) c |
Liv2018 | Cohort Study | Women | 20-29y | 7574 | Coffee: E1 ≤ 200 ml/d E2 200-400 ml/d E3 ≥ 500 ml/d | 0 ml/d | Infertile women | HR1 = 0.86(0.70–1.06); HR2 = 0.88(0.73–1.06); HR3 = 0.89(0.72–1.10); |
Tea: E1 ≤ 200 ml/d E2 200-400 ml/d E3 ≥ 500 ml/d | 0 ml/d | HR1 = 1.10(0.84–1.44); HR2 = 1.10(0.84–1.46); HR3 = 1.15(0.87–1.53); | ||||||
Caffeined: E1 ≤ 1-168 mg/d E2 169-333mg/d E3 334-579mg/d E4 ≥ 580 mg/d | 0 mg/d | HR1 = 0.93(0.58–1.49); HR2 = 0.91(0.57–1.47); HR3 = 0.97(0.60–1.55); HR4 = 0.93(0.58–1.50)e |